Missed an Industry Symposium on-site? No worries, the on-demand content of the below symposia will be available until 6 September 2024.
Industry Symposia at ECP 2023
On-Demand Content of Industry Sponsored Symposia
Sunday, 10 September 2023
LS-03 | Janssen Pharmaceutica NV: Precision medicine in uro-oncology: Unlocking the potential of biomarkers
Co-Chair: Eva Compérat | Henning Reis
Speakers: Eva Compérat | Henning Reis | Ray McDermott
Welcome and introductions
Eva Compérat, Austria | Henning Reis, Germany
Precision medicine in genitourinary cancers: Clinical landscape and new data
Ray McDermott, Ireland
Precision medicine: Utilising biomarker testing in bladder and prostate cancer
Eva Compérat, Austria | Henning Reis, Germany
Pathologist recap – Interactive Q&A
All faculty
Patient case: Addressing the diagnostic challenges of bladder cancer
Eva Compérat, Austria
Interactive Q&A
All faculty
Monday, 11 September 2023
LS-09 | Janssen Pharmaceutica NV and Roche: Decoding Non-Small Cell Lung Cancer: insights and Approaches for Precision Diagnosis
Chair: Umberto Malapelle
Speakers: Dearbhaile Collins | Umberto Malapelle | Léon van Kempen | Ana Peixoto
NSCLC, the frontrunner in precision medicine
Dearbhaile Collins, Ireland
Molecular tumour board goes live: Multidisciplinary discussion of NSCLC patient cases
Case 1: NGS/CGP Testing Takes the Lead: Unveiling the Benefits Over Single Gene Testing
Case 2: Liquid Biopsy: Tracking Progression and Complex Variants Interpretation
All faculty
Panel Discussion: Paving the Way: Genomic Testing Access & Future Developments
All faculty
Tuesday, 12 September 2023 | 13:00 - 14:30
LS-12 | Astellas: Escaping the maze of biomarker testing: A clear path for the future
Chair: Nicole van Grieken
Speakers: Maeve Lowery | Nicole van Grieken | Albrecht Stenzinger
Welcome and introductions
Nicole van Grieken, The Netherlands
Clues to the exit: Biomarkers in the treatment of G/GEJ adenocarcinoma
Maeve Lowery, Ireland
Revealing a clear path: Achieving onsistency
in biomarker testing
Nicole van Grieken, The Netherlands
Navigating the day-to-day changes and
challenges of the IVDR
Albrecht Stenzinger, Germany
Are we ready for action?
All Faculty
Q&A session
All Faculty
Symposium summary and close
Nicole van Grieken, The Netherlands
LS-14 | PER: Pathology Implications for CEACAM5 As a Therapeutic Target in Advanced NSCLC
Chair: Martin F. Dietrich
Speakers: Shirley M. Shiller | Martin F. Dietrich
Welcome, Introductions, Pre-Session Survey
Martin F. Dietrich, USA
Targeting CEACAM5 in NSCLC: Clinical
Rationale and Testing Strategies
Speaker tbd
Clinical Validation of CEACAM5 as a
Therapeutic Target
Shirley M. Shiller, USA
Panel Discussion
All Faculty
Question and Answer Session
Martin F. Dietrich, USA